Gilead Sciences Inc. (GILD): Price and Financial Metrics
GILD Price/Volume Stats
| Current price | $109.64 | 52-week high | $119.96 |
| Prev. close | $114.54 | 52-week low | $69.91 |
| Day low | $109.45 | Volume | 6,116,200 |
| Day high | $113.81 | Avg. volume | 8,773,436 |
| 50-day MA | $107.48 | Dividend yield | 2.76% |
| 200-day MA | $99.74 | Market Cap | 136.38B |
GILD Stock Price Chart Interactive Chart >
Gilead Sciences Inc. (GILD) Company Bio
Gilead Sciences Inc. is a biopharmaceutical company that discovers, develops, and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases. Daniel O’Day has been Gilead Science’s Chief Executive Officer since March of 2019 and the company is headquartered in Foster City, California. With over 10,000 employees worldwide, the company has operations in North America, Asia, the Middle East and Europe. As of 2019, the company had global sales of $22.1 billion. Some of Gilead Science’s major competitors are Novo Nordisk A/S ADR (NVO), Biogen Inc. (BIIB), and Novartis AG ADR (NVS).
GILD Price Returns
| 1-mo | -0.31% |
| 3-mo | 4.48% |
| 6-mo | 20.37% |
| 1-year | 61.77% |
| 3-year | 95.81% |
| 5-year | 74.74% |
| YTD | 20.38% |
| 2024 | 18.68% |
| 2023 | -1.99% |
| 2022 | 23.63% |
| 2021 | 29.95% |
| 2020 | -6.70% |
GILD Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching GILD
Want to do more research on Gilead Sciences Inc's stock and its price? Try the links below:Gilead Sciences Inc (GILD) Stock Price | Nasdaq
Gilead Sciences Inc (GILD) Stock Quote, History and News - Yahoo Finance
Gilead Sciences Inc (GILD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...